The Dermatology Digest

JANUARY 9, 2025

Artificial intelligence (AI) can determine the course and severity of Merkel cell carcinomas (MCC), enhancing clinical decision making, a new study suggests. For the study, researchers combined machine learning with clinical expertise to develop a web-based system called DeepMerkel which offers the power to predict MCC treatment-specific outcomes based on personal and tumour specific features.

Tools 36

Tools Clinic Hospital Dermatology 36

Dermatology Times

JANUARY 9, 2025

A study revealed ruxolitinib cream's rapid, lasting benefits in pediatric eczema without systemic safety concerns over a 52-week trial period.

Eczema 74

Eczema Safety 74

Salon Today

JANUARY 9, 2025

Incoming Intercoiffure President Scott Buchanan outlines his goals for the prestigious association and appoints Sonya Dove as its newest artistic director.

59

59

Dermatology Times

JANUARY 9, 2025

Mitragotri said new innovations like ionic liquid-based delivery systems can offer better treatment for immunodermatological conditions.

Therapy 74

Therapy Innovations Treatments 74

Salon Today

JANUARY 9, 2025

Double-sided stations and a compact footprint help a California salon maximize revenue potential with 40 stations, six treatment rooms and a nail area. But it's Salon Midori's modern, industrial and organic vibe that helped it snag a Salon of Distinction award in our Salons of the Year competition.

Salon 59

Salon Treatments 59

Dermatology Times

JANUARY 9, 2025

A recent systemic review found FRM to be an effective treatment modality on its own for managing facial acne scars.

Scarring 56

Scarring Microneedling Facials Management 56

Dermatology Times

JANUARY 9, 2025

DFD-29, FDA-approved in 2024, revolutionizes rosacea management by addressing both erythema and inflammatory lesions with a novel extended-release formulation.

Rosacea 50

Rosacea Management 50

Beauty Launchpad

JANUARY 9, 2025

Award-winning Barber Steven Wren (@mrwrencuts) shares his advice for developing better time management skills in 2025.

Management 40

Management 40

Dermatology Times

JANUARY 9, 2025

The 5% dosage showed a 6-fold increase in normal hair count after just 5 weeks.

Treatments 34

Treatments 34

The Dermatology Digest

JANUARY 9, 2025

The activity of macrophages may be used to predict whether a melanoma patient will respond to immunotherapy, according to a study in JCO Oncology Advances. For the study, researchers examined novel biomarkers that may identify melanoma patients more likely to respond to talimogene laherparepvec (TVEC). TVEC is a modified oncolytic virus that is injected into melanoma directly to stimulate an immune response.

Injections 36

Injections Surgery Clinic Treatments 36

Dermatology Times

JANUARY 9, 2025

The recommendations place an emphasis on the utility of ultrasound-guided placement to enhance safety.

Safety 31

Safety 31